As in other solid organ transplants, adherence to the medical regimen after adult and pediatric lung transplantation is less than ideal and contributes to poor health outcomes.
a) How can we improve the prediction of which lung transplant recipients are at greatest risk for nonadherence?
b) What are the most efficient and effective ways of assessing nonadherence in the clinical setting?
c) Conduct clinical trials of interventions targeting the patient, clinician, system and environmental factors that are known to influence adherence after transplantation.
Voting on Ideas
Vote for your favorite ideas by clicking on the up arrow.To undo an upvote, simply click the arrow again. This second click removes your vote.